Special delivery: bacterial couriers are smuggling drugs into cancers

AI Insight

Researchers are developing bacterial delivery systems that can transport cancer treatments directly to tumor sites. These microbial couriers have the potential to enhance the safety and effectiveness of existing cancer therapies including chemotherapy, radiotherapy, and immunotherapy by improving targeted delivery to malignant cells while reducing damage to healthy tissue.

Why it matters

This approach could address a major limitation of current cancer treatments: their lack of specificity often causes severe side effects by damaging healthy cells. Bacterial carriers may enable lower therapeutic doses while maintaining or improving treatment efficacy, potentially transforming cancer care by making treatments more tolerable for patients.